Neurobiology of emotion perception II: Implications for major psychiatric disorders

Biological Psychiatry

Volumn 54, Issue 5, 2003, Pages 515-528

  Phillips, Mary L ^a   Drevets, Wayne C ^b   Rauch, Scott L ^c   Lane, Richard ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Depression; Emotion; Neuroanatomy; Schizophrenia

Indexed keywords

FLUOXETINE; LITHIUM; SEROTONIN UPTAKE INHIBITOR;

AFFECT; AMYGDALOID NUCLEUS; ANHEDONIA; BIPOLAR DISORDER; BRAIN REGION; BRAIN STEM; CINGULATE GYRUS; COGNITIVE DEFECT; CORPUS STRIATUM; DELUSION; EMOTION; EVIDENCE BASED MEDICINE; HIPPOCAMPUS; HUMAN; INSULA; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL INSTABILITY; MOOD DISORDER; NEUROANATOMY; NEUROBIOLOGY; ORBITAL CORTEX; PERCEPTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; STIMULUS RESPONSE; SYMPTOMATOLOGY; TECHNIQUE; THALAMUS;

EID: 0142042993     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00171-9     Document Type: Review

References (147)

1. Abercrombie H.C., Schaefer S.M., Larson C.L., Oakes T.R., Lingren K.A., Holden J.E., et al. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport. 9:1998;3301-3307.
2. Altshuler L.L., Bartzokis G., Grieder T., Curran J., Jimenez T., Leight K., et al. An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol Psychiatry. 48:2000;147-162.
3. Altshuler L.L., Bartzokis G., Grieder T., Curran J., Mintz J. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia An MRI study demonstrating neuroanatomic specificity . Arch Gen Psychiatry. 55:1998;663-664.
4. Andreasen N.C., Ehrhardt J.C., Swayzee V.W., Alliger R.J., Yuh R.T., Cohen G., et al. Magnetic resonance imaging the brain in schizophrenia The pathophysiologic significance of structural abnormalities . Arch Gen Psychiatry. 47:1990;35-44.
5. Andreasen N.C., Boles Ponto L.L., O'Leary D.S., Flaum M., Nopoulos P., Watkins G.L., et al. Hypofrontality in schizophrenia Distributed dysfunctional circuits in neuroleptic-naive patients . Lancet. 349:1997;1730-1734.
6. Andreasen N.C., Paradiso S., O'Leary D.S. Cognitive dysmetria as an integrative theory of schizophrenia A dysfunction in cortical-subcortical- cerebellar circuitry? Schizophr Bull. 24:1998;203-218.
7. Ashtari M., Greenwald B.S., Kramer-Ginsberg E., Hu J., Wu H., Patel M., et al. Hippocampal/amygdala volumes in geriatric depression. Psychol Med. 29:1999;629-638.
8. Austin M.P., Mitchell P., Goodwin G.M. Cognitive deficits in depression. Possible implicaitons for funcitonal neuropathology. Br J Psychiatry. 178:2001;200-206.
9. Aylward E.H., Roberts-Twillie J.V., Barta P.E., Kumar A.J., Harris G.J., Geer M., et al. Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry. 151:1994;687-693.
10. Baxter L.R., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Selin C.E., et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 46:1989;243-250.
11. Bearden C.E., Hoffman K.M., Canon T.D. The neuropsychology and neuroanatomy of bipolar affective disorder A critical review . Bipolar Disord. 3:2001;106-150.
12. Bell M., Bryson G., Lysaker P. Positive and negative affect recognition in schizophrenia A comparison with substance abuse and normal control subjects . Psychiatr Res. 73:1997;73-82.
13. Bench C.J., Friston K.J., Brown R.G., Frackowiak R.S., Dolan R.J. Regional cerebral blood flow in depression measured by positron emission tomography The relationship with clinical dimensions . Psychol Med. 23:1993;579-590.
14. Benes F.M., Berretta S. Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia. Ann N Y Acad Sci. 911:2000;293-304.
15. Benes F.M., Kwok E.W., Vincent S.L., Todtenkopf M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry. 44:1998;88-97.
16. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices in schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 48:1991;996-1001.
17. Bernstein H.G., Krell D., Baumann B., Danos P., Falkai P., Diekmann S., et al. Morphometric studies of the entorhinal cortex in neuropsychiatric patients and control subjects Clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia . Schizophr Res. 33:1998;125-132.
18. Bleuler E. Dementia Praecox or the Group of Schizophrenias. 1950;International University Press, New York, NY.
19. Blumberg H.P., Stern E., Martinez D., Ricketts S., de Asis J., White T., et al. Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry. 48:2000;1945-1952.
20. Blumberg H.P., Stern E., Ricketts S., Martinez D., de Asis J., White T., et al. Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry. 156:1999;1986-1988.
21. Borkowska A., Rybakowski J.K. Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. Bipolar Disord. 3:2001;88-94.
22. Botteron K., Raichle M., Drevets W.C., Heath A., Todd R.D. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biol Psychiatry. 51:2002;342-344.
23. Bowley M.P., Drevets W.C., Ongur D., Price J.L. Low glial cell numbers in the amygdala in major depressive disorder. Biol Psychiatry. 52:2002;404-412.
24. Bradley B.P., Mogg K., Millar N. Implicit memory bias in clinical and non-clinical depression. Behav Res Ther. 34:1996;865-879.
25. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., Charney D.S. Hippocampal volume reduction in major depression. Am J Psychiatry. 157:2000;115-118.
26. Bremner J.D., Vythilingham M., Vermetten E., Nazeer A., Adil J., Khan S., et al. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry. 51:2002;273-279.
27. Brody A.L., Saxena S., Silverman D.H., Alborzian S., Fairbanks L.A., Phelps M.E., et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res. 91:1999;127-139.
28. Brody A.L., Saxena S., Stoessel P., Gillies L.A., Fairbanks L.A., Alborzian S., et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy Preliminary findings . Arch Gen Psychiatry. 58:2001;631-640.
29. Buchsbaum M.S., Wu J., DeLisi L.E., Holcomb H., Kessler R., Johnson J., et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F] 2-deoxyglucose in affective illness. J Affect Disord. 10:1986;137-152.
30. Buchsbaum M.S., Wu J., Siegel V., Hackett E., Trenary M., Abel L., et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry. 41:1997;15-22.
31. Bulbena A., Berrios G.E. Cognitive function in the affective disorders A prospecitve study . Psychopathology. 26:1993;6-12.
32. Caetano S.C., Sassi R., Brambilla P., Harenski K., Nicoletti M., Mallinger A.G., et al. MRI study of thalamic volumes in bipolar and unipolar patients and healthy individuals. Psychiatry Res. 108:2001;161-168.
33. Carter C.S., Perlstein W., Ganguli R., Brar J., Mintun M., Cohen J.D. Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry. 155:1998;1285-1287.
34. Chance S.A., Esiri M.M., Crow T.J. Amygdala volume in schizophrenia Post-mortem study and review of magnetic imaging findings . Br J Psychiatry. 180:2002;331-338.
35. Clark L., Iversen S.D., Goodwin G.M. Sustained attention deficit in bipolar disorder. Br J Psychiatry. 180:2002;313-319.
36. Coffey C.E., Wilkinson W.E., Weiner R.D., Parashos I.A., Djang W.T., Webb M.C., et al. Quantitative cerebral anatomy in depression A controlled magnetic resonance imaging study . Arch Gen Psychiatry. 50:1993;7-16.
37. Corcoran R., Cahill C., Frith C.D. The appreciation of visual jokes in people with schizophrenia A study of "mentalizing" ability . Schizophr Res. 24:1997;319-327.
38. Cotter D., Mackay D., Landau S., Kerwin R., Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry. 58:2001;545-553.
39. Crespo-Facorro B., O'Leary D.S., Bockholt H.J., Magnotta V., Kim J., Andreasen N.C. Insular cortex abnormalities in schizophrenia: A structural magnetic resonance imaging study of first-episode patients. Schizophr Res. 46:2000;35-43.
40. Crespo-Facorro B., Paradiso S., Andreasen N.C., O'Leary D.S., Watkins G.L., Ponto L.L.B., et al. Neural mechanisms of anhedonia in schizophrenia. JAMA. 286:2001;427-435.
41. Dasari M., Friedman L., Jesberger J., Stuve T.A., Findling R.L., Swales T.P., et al. A magnetic resonance imaging study of thalamic area in adolescent patients with either schizophrenia or bipolar disorder as compared to healthy controls. Psychiatry Res. 91:1999;155-162.
42. David A.S., Cutting J. Affect, affective disorder and schizophrenia A neuropsychological investigation of right hemisphere function . Br J Psychiatry. 156:1990;491-495.
43. Drevets W.C. Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci. 877:1999;614-637.
44. Drevets W.C. Neuroimaging studies of mood disorders. Biol Psychiatry. 48:2000;813-829.
45. Drevets W.C., Bogers W., Raichle M.E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol. 12:2002;527-544.
46. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:1997;824-827.
47. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. J Neurosci. 12:1992;3268-3641.
48. Edwards J., Pattison P.E., Jackson H.J., Wales R.J. Facial affect and affective prosody recognition in first-episode schizophrenia. Schizophr Res. 48:2001;235-253.
49. Elliott R. The neuropsychological profile in unipolar depression. Trends Cognit Sci. 2:1998;447-454.
50. Elliott R., Rubinsztein J.S., Sahakian B.J., Dolan R.J. The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry. 59:2002;597-604.
51. Evangeli M., Broks P. Face processing in schizophrenia Parallels with the effects of amygdala damage . Cognit Neuropsychiatry. 5:2000;81-104.
52. Falkai P., Bogerts B. Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci. 236:1986;154-161.
53. Feinberg T.E., Rifkin A., Scaffer C., Walker E. Facial discrimination and emotional recognition in schizophrenia and affective disorders. Arch Gen Psychiatry. 43:1986;276-279.
54. Flack W.F. Jr, Cavallaro L.A., Laird J.D., Miller D.R. Accurate encoding and decoding of emotional facial expressions in schizophrenia. Psychiatry. 60:1997;197-210.
55. Flack W.F. Jr, Laird J.D., Cavallaro L.A. Emotional expression and feeling in schizophrenia Effects of specific expressive behaviours on emotional experiences . J Clin Psychol. 55:1998;1-20.
56. Fletcher P.C., Frith C.D., Grasby P.M., Friston K.J., Dolan R.J. Local and distributed effects of apomorphine in fronto-temporal function in acute unmedicated schizophrenia. J Neurosci. 16:1996;7055-7070.
57. Frith C. The Cognitive Neuropsychology of Schizophrenia. 1992;Lawrence Erlbaum Associates, Hove, UK.
58. Fudge J.L., Powers J.M., Haber S.N., Caine E.D. Considering the role of the amygdala in psychotic illness A clinicopathological correlation . J Neuropsychiatry Clin Neurosci. 10:1998;383-394.
59. Garety P.A., Hemsley D.R., Wessely S. Reasoning in deluded schizophrenic and paranoid patients. Biases in performance on a probablilistic inference task. J Nerv Ment Dis. 179:1991;194-201.
60. Goldberg T.E., Gold J.M., Greenberg R., Griffin S., Schulz S.C., Pickar D., et al. Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry. 150:1993;1355-1362.
61. Goldman-Rakic P.S. Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci. 6:1994;348-357.
62. Goldman-Rakic P.S., Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull. 23:1997;437-458.
63. Goodwin G.M., Cavanagh J.T., Glabus M.F., Kehoe R.F., O'Carroll R.E., Ebmeier K.P. Uptake of 99 mTc-exametazime shown by single photon emission computed tomography before and after lithium withdrawal in bipolar patients Associations with mania . Br J Psychiatry. 170:1997;426-430.
64. Green M.F., Kern R.S., Robertson M.J., Sergi M.J., Kee K.S. Relevance of neurocognitive deficits for functional outcome in schizophrenia. Sharma T., Harvey P. Cognition in Schizophrenia. 2000;178-192 Oxford University Press, Oxford.
65. Gur R.C., Erwin R.J., Gur R.E., Zwil A.S., Heimberg C., Kraemer H.C. Facial emotion discrimination II. Behavioral findings in depression . Psychiatry Res. 42:1992;241-251.
66. Gur R.E., McGrath C., Chan R.M., Schroeder L., Turner T., Turetsky B.I., et al. An fMRI study of facial emotion processing in patients with schizophrenia. Am J Psychiatry. 159:2002;1992-1999.
67. Gur R.W., Maany V., Mozley D., Swanson C., Bilker W., Gur R.C. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry. 155:1998;1711-1717.
68. Gyulai L., Alavi A., Broich K., Reilley J., Ball W.B., Whybrow P.C. I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder A clinical study . Biol Psychiatry. 41:1997;152-161.
69. Harmer C.J., Grayson L., Goodwin G.M. Enhanced recognition of disgust in bipolar illness. Biol Psychiatry. 51:2002;298-304.
70. Harrison P.J. The neuropathology of primary mood disorder. Brain. 125:2002;1428-1449.
71. Harvey I., Persaud R., Ron M.A., Baker G., Murray R.M. Volumetric MRI measurements in bipolars compared with schizophrenics and healthy controls. Psychol Med. 24:1994;689-699.
72. Haznedar M.M., Buchsbaum M.S., Luu C., Hazlett E.A., Siegel B.V. Jr, Lohr J., et al. Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatry. 154:1997;682-684.
73. Heckers S. Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus. 11:2001;520-528.
74. Heckers S., Goff D., Schacter D.L., Savage C.R., Fischman A.J., Alpert N.M., et al. Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia. Arch Gen Psychiatry. 56:1999;1117-1123.
75. Heckers S., Konrad C. Hippocampal neurons in schizophrenia. J Neural Transm. 109:2002;891-905.
76. Heckers S., Rauch S.L., Goff D., Savage C.R., Schacter D.L., Fischman A.J., et al. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci. 1:1998;318-323.
77. Hirayasu H., Shenton M.E., Salisbury D.F., Kwon J.S., Wible C.G., Fischer I.A., et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry. 156:1999;1091-1093.
78. Husain M.M., McDonald W.M., Doraiswamy P.M., Fliegel G.S., Na C., Escalona P.R., et al. A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res. 40:1991;95-99.
79. Kennedy S.H., Evans K.R., Kruger S., Mayberg H.S., Meyer J.H., McCann S., et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry. 158:2001;899-905.
80. Kerr S.L., Neale J.M. Emotion perception in schizophrenia Specific deficit or further evidence of generalized poor performance? J Abnorm Psychol. 102:1993;312-318.
81. Ketter T.A., Kimbrell T.A., George M.S., Dunn R.T., Speer A.M., Benson B.E., et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry. 49:2001;97-109.
82. Kline J.S., Smith J.E., Ellis H.C. Paranoid and nonparanoid schizophrenic processing of facially displayed affect. J Psychiatr Res. 26:1992;169-182.
83. Kohler C.G., Bilker W., Hagendoorn M., Gur R.E., Gur R.C. Emotion recognition deficit in schizophrenia Association with symptomatology and cognition . Biol Psychiatry. 48:2000;127-136.
84. Konick L.C., Friedman L. Meta-analysis of thalamic size in schizophrenia. Biol Psychiatry. 49:2001;28-38.
85. Kosaka H., Omori M., Murata T., Iidaka T., Yamada H., Okada T., et al. Differential amygdala response during facial recognition in patients with schizophrenia An fMRI study . Schizophr Res. 57:2002;87-95.
86. Krishnan K.R., McDonald W.M., Escalona P.R., Doraiswamy P.M., Na C., Husain M.M., et al. Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch Gen Psychiatry. 49:1992;553-557.
87. Laasko M.P., Tiihonen J., Syvalahti E., Vilkman H., Laakso A., Alakare B., et al. A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naive schizophrenia. Schizophr Res. 50:2001;3-7.
88. Lawrie S.M., Abukmeil S.S. Brain abnormality in schizophrenia A systematic and quantitative review of volumetric magnetic resonance imaging studies . Br J Psychiatry. 172:1998;110-120.
89. Lenze E.J., Sheline Y.I. Absence of striatal volume differences between depressed subjects with no comorbid medical illness and matched comparison subjects. Am J Psychiatry. 156:1999;1989-1991.
90. Liddle P.F., Friston K.J., Frith C.D. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry. 160:1992;179-186.
91. Liddle P.F., Morris D.L. Schizophrenia syndromes and frontal lobe performance. Br J Psychiatry. 158:1991;340-345.
92. Lopez-Larson M.P., DelBello M.P., Zimmerman M.E., Schwiers M.L., Strakowski S.M. Regional prefrontal gray and white matter abnormalities in bipolar disorder. Biol Psychiatry. 52:2002;93-100.
93. Lyon H.M., Startup M., Bentall R.P. Social cognition and the manic defense Attributions, selective attention, and self-schema in bipolar affective disorder . J Abnorm Psychol. 108:1999;273-282.
94. Manji H.K., Moore G.J., Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers Implications for the pathophysiology and treatment of manic-depressive illness . Biol Psychiatry. 48:2000;740-754.
95. Martin S.D., Martin E., Rai S.S., Richardson M.A., Royall R. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride. Arch Gen Psychiatry. 58:2001;641-648.
96. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., et al. Cingulate function in depression A potential predictor of treatment response . Neuroreport. 8:1997;i-ii.
97. Mayberg H.S., Brannan S.K., Tekell J.L., Silva A., Mahurin R.K., McGinnis S., et al. Regional metabolic effects of fluoxetine in major depression Serial changes and relationship to clinical response . Biol Psychiatry. 48:2000;830-843.
98. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jarabek P.A., et al. Reciprocal limbic-cortical function and negative mood Converging PET findings in depression and normal sadness . Am J Psychiatry. 156:1999;675-682.
99. Medoff D.R., Holcomb H.H., Lahti A.C., Tamminga C.A. Probing the human hippocampus using rCBF Contrasts in schizophrenia . Hippocampus. 11:2001;543-550.
100. Mueser K.T., Penn D.L., Blanchard J.J., Bellack A.S. Affect recognition in schizophrenia A synthesis of findings across three studies . Psychiatry. 60:1997;301-308.
101. Murphy F.C., Rubinsztein J.S., Michael A., Rogers R.D., Robbins T.W., Paykel E.S., Sahakian B.J. Decision-making cognition in mania and depression. Psychol Med. 31:2001;679-693.
102. Murphy F.C., Sahakian B.J., Rubinsztein J.S., Michale A., Rogers R.D., Robbins T.W., Paykel E.S. Emotional bias and inhibitory control processes in mania and depression. Psychol Med. 29:1999;1307-1321.
103. Nasrallah H.A., Skinner T.E., Schmalbrock P., Robitaille P.M. Proton magnetic resonance spectroscopy (iH MRS) of the hippocampal formation in schizophrenia A pilot study . Br J Psychiatry. 165:1994;481-485.
104. Nelson M.D., Saykin A.J., Flashman L.A., Riordan H.J. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging A meta-analytic study . Arch Gen Psychiatry. 55:1998;433-440.
105. Nobler M.S., Sackeim H.A., Prohovnik I., Moeller J.R., Mukherjee S.S.D.B., et al. Regional cerebral blood flow in mood disorders, III. Tretament and clinical response. Arch Gen Psychiatry. 51:1994;884-897.
106. O'Connell R.A., Van Heertum R.L., Luck D., Yudd A.P., Cueva J.E., Billick S.B., et al. Single-photon emission computed tomography of the brain in acute mania and schizophrenia. J Neuroimaging. 5:1995;101-104.
107. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 95:1998;13290-13295.
108. Pantel J., Schroder J., Essig M., Popp D., Dech H., Knopp M.V., et al. Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia. J Affect Disord. 42:1997;69-83.
109. Paradiso S., Lamberty G.J., Garvey M.J., Robinson R.G. Cognitive impairment in the euthymic phase of chronic unipolar depression. J Nerv Ment Dis. 185:1997;748-754.
110. Pearlson G.D., Marsh L. Structural brain imaging in schizophrenia A selective review . Biol Psychiatry. 46:1999;627-649.
111. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception I The neural basis of normal emotion perception . Biol Psychiatry. 54:2003;504-514.
112. Phillips M.L., Senior C., David A.S. Perception of threat in schizophrenics with persecutory delusions An investigation using visual scan paths . Psychol Med. 30:2000;157-167.
113. Phillips M.L., Williams L., Senior C., Bullmore E.T., Brammer M.J., Andrew C., et al. A differential neural response to threatening and non-threatening negative facial expressions in paranoid and non-paranoid schizophrenics. Psychiatry Res. 92:1999;11-31.
114. Premack D., Woodruff G. Does the chimpanzee have a theory of mind? Behav Brain Sci. 4:1978;515-526.
115. Rajarethinam R., DeQuardo J.R., Miedler J., Arndt S., Kirbat R., Brunberg J.A., et al. Hippocampus and amygdala in schizophrenia Assessment of the relationship of neuroanatomy to psychopathology . Psychiatry Res. 108:2002;79-87.
116. Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord. 4:2002;105-116.
117. Rajkowska G., Halaris A., Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry. 49:2001;741-752.
118. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 48:1999;486-504.
119. Rajkowska G., Selemon L.D., Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex A postmortem morphometric study of schizophrenia and Huntington disease . Arch Gen Psychiatry. 55:1998;215-224.
120. Rubinow D.R., Post R.M. Impaired recognition of affect in facial expression in depressed patients. Biol Psychiatry. 31:1992;947-953.
121. Rubinsztein J.S., Fletcher P.C., Rogers R.D., Ho L.W., Aigbirhio F.I., Paykel E.S., et al. Decision-making in mania A PET study . Brain. 124:2001;2550-2563.
122. Sapin L.R., Berrettini W.H., Nurnberger J.I., Rothblat L. Mediational factors underlying cognitive changes and laterality in affective illness. Biol Psychiatry. 22:1987;979-986.
123. Schneider F., Weiss U., Kessler C., Salloum J.B., Posse S., Grodd W., et al. Differential amygdala activation in schizophrenia during sadness. Schizophr Res. 34:1998;133-142.
124. Seidman L.J., Faraone S.V., Goldstein J.M., Goodman J.M., Kremen W.S., Toomey R., et al. Thalamic and amygdala-hippocampal volume reductions in first-degree relatives of patients with schizophrenia An fMRI-based morphometric analysis . Biol Psychiatry. 46:1999;941-954.
125. Sheline Y.I. 3D MRI studies of neuroanatomic changes in unipolar major depression The role of stress and medical comorbidity . Biol Psychiatry. 48:2000;791-800.
126. Sheline Y.I., Barch D.M., Donnelly J.M., Ollinger J.M., Snyder A.Z., Mintun M.A. Increased amygdalar response to masked emotional faces in depressed subjects resolves with antidepressant treatment An fMRI study . Biol Psychiatry. 50:2001;651-659.
127. Sheline Y.I., Gado M.H., Price J.L. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport. 9:1998;2023-2028.
128. Sheline Y.I., Sanghavi M., Mintun M.A., Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci. 19:1999;5034-5043.
129. Shenton M.E., Kikinis R., Jolesz F.A., Pollak S.D., LeMay M., Wible C.G., et al. Abnormalities in the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N Engl J Med. 327:1992;604-612.
130. Siegle G., Steinhauer S.R., Thase M.E., Stenger A., Carter C.S. Can't shake that feeling Event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals . Biol Psychiatry. 51:2002;693-707.
131. Silfverskiold P., Risberg J. Regional cerebral blood flow in depression and mania. Arch Gen Psychiatry. 46:1989;253-259.
132. Smith G.S., Reynolds C.F., Pollock B., Derbyshire S., Nofzinger E., Dew M.A., et al. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. Am J Psychiatry. 156:1999;683-689.
133. Smith M.J. Experimental evidence for two dimensions of cognitive disorders in depressives. J Psychiatr Res. 28:1994;401-411.
134. Soares J.C., Mann J.J. The functional neuroanatomy of mood disorders. J Psychiatr Res. 31:1997;393-432.
135. Strakowski S.M., DelBello M.P., Sax K.W., Zimmerman M.E., Shear P.K., Hawkins J.M., et al. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry. 56:1999;254-260.
136. Surguladze S, Senior C, Brebien G, Young AW, Travis MJ, Phillips ML (in press): Recognition accuracy and response bias to happy and sad facial expressions in patients with major depression. Neuropsychology.
137. Sweeney J.A., Kmiec J.A., Kupfer D.J. Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB Neurocognitive Battery. Biol Psychiatry. 48:2000;674-685.
138. Taylor S.F., Liberzon I., Decker L.R., Koeppe R.A. A functional anatomic study of emotion in schizophrenia. Schizophr Res. 5:2002;159-172.
139. van Gorp W.G., Altshuler L., Theberge D.C., Wilkins J., Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry. 55:1998;41-46.
140. Weinberger D.R. On localizing schizophrenic neuropathology. Schizophr Bull. 23:1997;537-540.
141. Whittaker J.F., Deakin J.F.W., Tomenson B. Face processing in schizophrenia Defining the deficit . Psychol Med. 31:2001;499-507.
142. Wilder-Willis K.E., Sax K.E., Rosenberg H.L., Fleck D.E., Shear P.K., Strakowski S.M. Persistent attentional dysfunction in remitted bipolar disorder. Bipolar Disord. 3:2001;58-62.
143. Williams J.M.G., Mathews A., Macleod C. The emotional Stroop and psychopathology. Psychol Bull. 120:1996;3-24.
144. Wright I.C., Rabe-Hesketh S., Woodruff P.W.R., David A.S., Murray R.M., Bullmore E.T. Regional brain structure in schizophrenia A meta-analysis of volumetric MRI studies . Am J Psychiatry. 157:2000;16-25.
145. Young H.F., Bentall R. Hypothesis testing in patients with persecutory delusions Comparison with depressed and normal subjects . Br J Clin Psychol. 34:1995;353-369.
146. Yurgelun-Todd D.A., Gruber S.A., Kanayama G., Killgore W.D., Baird A.A., Young A.D. FMRI during affect discrimination in bipolar affective disorder. Bipolar Disord. 2:2000;237-248.
147. Zuffante P., Leonard C.M., Kuldau J.M., Bauer R.M., Doty E.G., Bilder R.M. Working memory deficits in schizophrenia are not necessarily specific or associated with MRI-based estimates of area 46 volumes. Psychiatry Res. 108:2001;187-209.